Renovaro Biosciences (RENB) - 2020 Q2 - Quarterly Report

Commission file number 000-54478 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Enochian Biosciences, Inc. (Exact name of registrant as specified in its charter) Delaware 45-2259340 (State or other jur ...